article thumbnail

STAT+: Biden invokes Defense Production Act to stem drug shortages

STAT

WASHINGTON — President Biden is using a Cold War-era law to stem drug shortages by boosting domestic pharmaceutical manufacturing. The White House will spend $35 million to boost domestic production of key starting materials for sterile injectables, which are the drugs that hospitals commonly use and are most prone to shortages.

article thumbnail

ICEXPO announces Pharma Live Expo 2025 in Mumbai from April 17-19

Express Pharma

Bringing together over 225+ exhibitors and showcasing 12000+ products and solutions, the expo will represent diverse industries, including pharmaceutical manufacturing, biotechnology, medical devices and diagnostics, cosmeceuticals, nutraceuticals, packaging solutions, and healthcare IT.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CPHI & PMEC India expo to be held from Nov 26-28, 2024

Express Pharma

A marketplace for innovation and growth With a comprehensive array of exhibitors, CPHI & PMEC India enables direct engagement with pharmaceutical executives, buyers, hospital administrators, and government representatives.

article thumbnail

Navigating 340B Program Changes in 2025

Proxsys Rx

Maximizing pharmacys role in your hospitals revenue cycle The 340B landscape continues to evolve rapidly, with ongoing manufacturer restrictions, new compliance hurdles, and increasing financial pressures on covered entities. Recent estimates indicate that hospitals and clinics collectively lose around $3.2

article thumbnail

Responsible antibiotic use: How the industry can lead the way for evidence-backed guidelines

Express Pharma

According to ICMR, infections that were once easily treatable are now becoming resistant to widely used antibiotics, leading to prolonged hospital stays, higher mortality rates, and rising healthcare costs. Most of these drugs fail to address emerging bacterial mechanisms, exacerbating the crisis.

article thumbnail

FDA completes inspection of Nexus’ manufacturing facility in US

Pharmaceutical Business Review

It is designed to manufacture a broad range of injectable medications and will provide hospitals and clinicians access to affordable, safe, and critical-need medicines. Nexus Pharmaceuticals President and CEO Usman Ahmed said: “We are thrilled to receive the EIR for our Pleasant Prairie facility.

article thumbnail

FDA completes inspection of Nexus’ manufacturing facility in US

Pharma Leaders

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticalspharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.